Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Key Points

• AbbVie is a Dividend King with solid growth prospects.

• Enbridge is a leading pipeline operator and natural gas utility with an ultra-high dividend yield.

• Realty Income pays monthly dividends that are highly reliable.

There's a strong parallel between investing for passive income and planting an apple tree. Both require some work up front. But if all goes well, you can reap the fruits of those labors (literally, in the case of the apple tree) for years afterward.

Of course, there are some potential pitfalls. An apple tree could become diseased and stop bearing fruit. Similarly, the companies you invest in could struggle and stop distributing income.

The good news for investors is that selecting the right dividend stocks can minimize the risk of that happening. Want decades of passive income? Here are three stocks to buy now and hold forever.

Image source: Getty Images.

1. AbbVie

If you're looking for the companies with the best dividend track records, you'll want to check out the elite group of stocks known as the Dividend Kings. The list includes over 50 stocks. I think AbbVie (NYSE: ABBV) ranks as one of the best.

Many of the Dividend Kings don't offer kingly yields. However, AbbVie does. At its current share price, the drugmaker's forward dividend yield stands at 3.5%. Moreover, AbbVie has increased its payouts annually for 53 consecutive years. It has more than quadrupled its dividend since its spinoff from Abbott Laboratories in 2013.

You'll get more than just a dividend with AbbVie, though. The company should have solid growth prospects thanks to rising stars such as Rinvoq, Skyrizi, Ubrelvy, and Qulipta. AbbVie's pipeline looks promising as well, with around 90 programs in clinical development, roughly 50 of which are in mid- or late-stage testing.

Perhaps the most impressive thing about AbbVie, other than its dividend, is the company's resilience. Not long ago, it faced the loss of patent exclusivity for its top-selling product, the autoimmune disease drug Humira. Today, the company has two successors treatments to Humira that together are on track to be even bigger winners.

2. Enbridge

Want even more passive income? Consider investing in Enbridge (NYSE: ENB). At its current share price, this midstream energy leader offers a forward dividend yield that's a hair over 6%. And while Enbridge isn't a Dividend King like AbbVie, it has increased its payouts annually for an impressive 30 consecutive years.

Like AbbVie, Enbridge has a highly resilient business. Around 80% of its earnings before interest, taxes, depreciation, and amortization (EBITDA) are protected against inflation. Less than 1% of its EBITDA is tied to volatile commodity prices. Roughly 98% of its EBITDA is either regulated or contracted via take-or-pay agreements (where buyers commit to either purchase products or pay a penalty if they don't).

Enbridge is one of the biggest midstream energy companies. Its pipelines transport around 30% of the crude oil produced in North America and 40% of total U.S. crude oil imports. It also transports close to 20% of all natural gas used in the U.S.

In addition, thanks to some strategic acquisitions in 2023, Enbridge now ranks as the largest natural gas utility in North America by volume. This helps lower the company's risk level even more. I think Enbridge's utility business also makes the passive income the company generates more dependable.

3. Realty Income

Realty Income (NYSE: O) stacks up pretty well with Enbridge when it comes to dividends. The real estate investment trust (REIT) pays a forward dividend yield of 5.6% at the current share price. Realty Income has also boosted its dividend annually for 30 consecutive years.

Another attribute that will appeal to many investors is that Realty Income distributes its dividends monthly rather than quarterly. It even trademarked the name "The Monthly Dividend Company."

Realty Income has a strong tenant base, leasing properties to 1,598 different clients across 91 industries. Its triple-net leases generate nearly 100% gross margins since its tenants are responsible for covering major property expenses such as insurance, maintenance, property taxes, and utilities. These leases are also usually long, which provides the REIT with consistent, recurring revenue.

I also like Realty Income's long-term growth prospects. The company targets a total addressable market of around $14 trillion. More than 60% of this market is in Europe, where Realty Income faces only two major rivals.

Should you invest $1,000 in AbbVie right now?

Before you buy stock in AbbVie, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $976,677!*

Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of June 30, 2025

Keith Speights has positions in AbbVie, Enbridge, and Realty Income. The Motley Fool has positions in and recommends AbbVie, Abbott Laboratories, Enbridge, and Realty Income. The Motley Fool has a disclosure policy.